BlackRock Institutional Trust’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$2.39M Buy
184,833
+53,448
+41% +$823K ﹤0.01% 2995
2016
Q3
$2.15M Buy
131,385
+47,396
+56% +$856K ﹤0.01% 3018
2016
Q2
$1.04M Buy
83,989
+49,603
+144% +$620K ﹤0.01% 3295
2016
Q1
$368K Buy
34,386
+1,375
+4% +$12.5K ﹤0.01% 3517
2015
Q4
$484K Buy
+33,011
New +$404K ﹤0.01% 3513

Other funds holding MYOK

BlackRock Institutional Trust's MYOK Position: Q4 2016 in Review

BlackRock Institutional Trust increased its MyoKardia, Inc. Common Stock (MYOK) stake by 41% in Q4 2016, buying an estimated $823K and bringing the position to 184,833 shares worth $2.39M. The position accounts for ﹤0.01% of the portfolio, ranked #2995.

BlackRock Institutional Trust first reported a position in MYOK in Q4 2015 and has held it in 5 quarters since. 71 funds tracked by Wall St. Rank hold MYOK as of Q4 2016.

  • BlackRock Institutional Trust held 184,833 shares of MyoKardia, Inc. Common Stock worth $2.39M as of Q4 2016.
  • BlackRock Institutional Trust bought 53,448 MyoKardia, Inc. Common Stock shares in Q4 2016, an estimated $823K.
  • MyoKardia, Inc. Common Stock made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2995 holding.
  • BlackRock Institutional Trust first reported a position in MyoKardia, Inc. Common Stock in Q4 2015 and has held it in 5 quarters since.
  • 71 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.